Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma. [electronic resource] by
- Amengual, Jennifer E
- Lichtenstein, Renee
- Lue, Jennifer
- Sawas, Ahmed
- Deng, Changchun
- Lichtenstein, Emily
- Khan, Karen
- Atkins, Laine
- Rada, Aishling
- Kim, Hye A
- Chiuzan, Codruta
- Kalac, Matko
- Marchi, Enrica
- Falchi, Lorenzo
- Francescone, Mark A
- Schwartz, Lawrence
- Cremers, Serge
- O'Connor, Owen A
Producer: 20190513
In:
Blood vol. 131
Availability: No items available.
|